HEADER HYDROLASE 15-APR-07 2PJC TITLE CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC TITLE 2 CARBOXYPEPTIDASE B ({(R)-1-[(S)-2-BENZYLOXYCARBONYLAMINO-3- TITLE 3 (4-HYDROXY-PHENYL)-PROPIONYLAMINO]-2-METHYL-PROPYL}- TITLE 4 HYDROXY-PHOSPHINOYLOXY)-(3-GUANIDINO-PHENYL)-ACETIC ACID TITLE 5 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE B; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 EC: 3.4.17.2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823 KEYWDS CARBOXYPEPTIDASE B, EXOPEPTIDASE, PHOSPHINATE BASED KEYWDS 2 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.ADLER,M.WHITLOW REVDAT 3 24-FEB-09 2PJC 1 VERSN REVDAT 2 10-JUN-08 2PJC 1 JRNL REVDAT 1 22-JAN-08 2PJC 0 JRNL AUTH M.ADLER,B.BUCKMAN,J.BRYANT,Z.CHANG,K.CHU,K.EMAYAN, JRNL AUTH 2 P.HRVATIN,I.ISLAM,J.MORSER,D.SUKOVICH,C.WEST, JRNL AUTH 3 S.YUAN,M.WHITLOW JRNL TITL STRUCTURES OF POTENT SELECTIVE PEPTIDE MIMETICS JRNL TITL 2 BOUND TO CARBOXYPEPTIDASE B. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 64 149 2008 JRNL REFN ISSN 0907-4449 JRNL PMID 18219114 JRNL DOI 10.1107/S0907444907057228 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.ADLER,J.BRYANT,B.BUCKMAN,I.ISLAM,B.LARSEN, REMARK 1 AUTH 2 S.FINSTER,L.KENT,K.MAY,R.MOHAN,S.YUAN,M.WHITLOW REMARK 1 TITL CRYSTAL STRUCTURES OF POTENT THIOL-BASED REMARK 1 TITL 2 INHIBITORS BOUND TO CARBOXYPEPTIDASE B. REMARK 1 REF BIOCHEMISTRY V. 44 9339 2005 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.ISLAM,J.BRYANT,K.MAY,R.MOHAN,S.YUAN,L.KENT, REMARK 1 AUTH 2 J.MORSER,L.ZHAO,R.VERGONA,K.WHITE,M.ADLER, REMARK 1 AUTH 3 M.WHITLOW,B.O.BUCKMAN REMARK 1 TITL 3-MERCAPTOPROPIONIC ACIDS AS EFFICACIOUS REMARK 1 TITL 2 INHIBITORS OF ACTIVATED THROMBIN ACTIVATABLE REMARK 1 TITL 3 FIBRINOLYSIS INHIBITOR (TAFIA). REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 17 1349 2007 REMARK 1 REFN ISSN 0960-894X REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2404948.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.5 REMARK 3 NUMBER OF REFLECTIONS : 81347 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3260 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2250 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2240 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3291 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0040 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 81951 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6692 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 275 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7308 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 138 REMARK 3 SOLVENT ATOMS : 578 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.49000 REMARK 3 B22 (A**2) : 8.64000 REMARK 3 B33 (A**2) : -8.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.67 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.080 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.510 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.730 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 48.44 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ZN.PAR REMARK 3 PARAMETER FILE 4 : 343.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ZN.TOP REMARK 3 TOPOLOGY FILE 4 : 343.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PJC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-07. REMARK 100 THE RCSB ID CODE IS RCSB042439. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.080 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : SI(111) REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82012 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 21.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07500 REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36300 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1Z5R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CHLORIDE, TRIS, SODIUM REMARK 280 CACODYLATE, PEG 8000, PH 6.50, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.24350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.63950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.63950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.24350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 4 REMARK 465 THR A 5 REMARK 465 THR B 4 REMARK 465 THR B 5 REMARK 465 THR C 4 REMARK 465 THR C 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 29 50.89 -140.25 REMARK 500 ASN A 58 63.71 32.53 REMARK 500 TYR A 92 -53.14 -120.56 REMARK 500 LYS A 122 -57.26 -134.53 REMARK 500 SER A 199 -14.91 153.31 REMARK 500 ILE A 247 -60.06 -131.90 REMARK 500 ALA A 250 123.33 -171.58 REMARK 500 ASP A 273 -140.58 -109.87 REMARK 500 ILE A 280 54.21 -95.55 REMARK 500 LYS B 122 -44.70 -140.10 REMARK 500 SER B 199 -17.83 149.13 REMARK 500 ILE B 247 -56.30 -131.82 REMARK 500 ALA B 250 113.60 -173.97 REMARK 500 ASP B 273 -140.51 -109.08 REMARK 500 ILE B 280 56.13 -94.01 REMARK 500 LYS C 122 -71.65 -133.13 REMARK 500 THR C 129 -174.51 -67.92 REMARK 500 SER C 199 -15.82 149.66 REMARK 500 ASN C 215 40.74 -95.38 REMARK 500 ILE C 247 -58.94 -130.32 REMARK 500 ASP C 273 -141.08 -109.67 REMARK 500 ILE C 280 57.19 -93.68 REMARK 500 HIS C 307 47.42 -142.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 400 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 500 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 600 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 343 A 401 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 343 B 501 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 343 C 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z5R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B REMARK 900 RELATED ID: 1ZG7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 2-(5-{[AMINO(IMINO)METHYL]AMINO}-2- REMARK 900 CHLOROPHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED REMARK 900 PORCINE PANCREATIC CARBOXYPEPTIDASE B REMARK 900 RELATED ID: 1ZG8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF (R)-2-(3-{[AMINO(IMINO)METHYL]AMINO} REMARK 900 PHENYL)-3-SULFANYLPROPANOIC ACID BOUND TO ACTIVATED PORCINE REMARK 900 PANCREATIC CARBOXYPEPTIDASE B REMARK 900 RELATED ID: 1ZG9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 5-{[AMINO(IMINO)METHYL]AMINO}-2- REMARK 900 (SULFANYLMETHYL)PENTANOIC ACID BOUND TO ACTIVATED PORCINE REMARK 900 PANCREATIC CARBOXYPEPTIDASE B REMARK 900 RELATED ID: 2PIY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B (S)-2-(3-AMINOMETHYL-PHENYL)-3-{HYDROXY- REMARK 900 [(R)-2-METHYL-1-(3-PHENYL-PROPANE-1-SULFONYLAMINO)-PROPYL]- REMARK 900 PHOSPHINOYL}-PROPIONIC ACID {ZK 528} COMPLEX REMARK 900 RELATED ID: 2PIZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-GUANIDINO-PHENYL)-3-[HYDROXY-(3- REMARK 900 PHENYL-PROPYL)-PHOSPHINOYL]-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B [((R)-1-BENZYLOXYCARBONYLAMINO-2-METHYL- REMARK 900 PROPYL)-HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC REMARK 900 ACID COMPLEX REMARK 900 RELATED ID: 2PJ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B (3-AMINOMETHYL-PHENYL)-[((R)-1- REMARK 900 BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY- REMARK 900 PHOSPHINOYLOXY]-ACETIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-[((R)-1- REMARK 900 BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY- REMARK 900 PHOSPHINOYL]-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B (3-GUANIDINO-PHENYL)-{HYDROXY-[(R)-2- REMARK 900 METHYL-1-(3-PHENYL-PROPIONYLAMINO)-PROPYL]-PHOSPHINOYLOXY}- REMARK 900 ACETIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B [((R)-BENZYLOXYCARBONYLAMINO-CYCLOHEXYL- REMARK 900 METHYL)-HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC REMARK 900 ACID COMPLEX REMARK 900 RELATED ID: 2PJ5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B [((R)-1-BENZYLOXYCARBONYLAMINO-HEXYL)- REMARK 900 HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC ACID REMARK 900 COMPLEX REMARK 900 RELATED ID: 2PJ6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{HYDROXY-[(R) REMARK 900 -2-METHYL-1-(2-PHENYL-ETHANESULFONYLAMINO)-PROPYL]- REMARK 900 PHOSPHINOYL}-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-[((R)-1- REMARK 900 BENZENESULFONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYL]- REMARK 900 PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[(R)-1- REMARK 900 (BIPHENYL-4-SULFONYLAMINO)-2-METHYL-PROPYL]-HYDROXY- REMARK 900 PHOSPHINOYL}-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJ9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[(R)-1- REMARK 900 (BENZO[1,2,5]THIADIAZOLE-4-SULFONYLAMINO)-2-METHYL-PROPYL]- REMARK 900 HYDROXY-PHOSPHINOYL}-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 3-{[(R)-1-((S)-2-BENZYLOXYCARBONYLAMINO- REMARK 900 3-PHENYL-PROPIONYLAMINO)-2-METHYL-PROPYL]-HYDROXY- REMARK 900 PHOSPHINOYL}-2-(3-GUANIDINO-PHENYL)-PROPIONIC ACID COMPLEX REMARK 900 RELATED ID: 2PJB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC REMARK 900 CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[1-((S)-2- REMARK 900 BENZYLOXYCARBONYLAMINO-3-PHENYL-PROPANE-1-SULFONYLAMINO)-2- REMARK 900 METHYL-PROPYL]-HYDROXY-PHOSPHINOYL}-PROPIONIC ACID COMPLEX DBREF 2PJC A 4 308 UNP P09955 CBPB1_PIG 111 416 DBREF 2PJC B 4 308 UNP P09955 CBPB1_PIG 111 416 DBREF 2PJC C 4 308 UNP P09955 CBPB1_PIG 111 416 SEQRES 1 A 306 THR THR GLY HIS SER TYR GLU LYS TYR ASN ASN TRP GLU SEQRES 2 A 306 THR ILE GLU ALA TRP THR LYS GLN VAL THR SER GLU ASN SEQRES 3 A 306 PRO ASP LEU ILE SER ARG THR ALA ILE GLY THR THR PHE SEQRES 4 A 306 LEU GLY ASN ASN ILE TYR LEU LEU LYS VAL GLY LYS PRO SEQRES 5 A 306 GLY PRO ASN LYS PRO ALA ILE PHE MET ASP CYS GLY PHE SEQRES 6 A 306 HIS ALA ARG GLU TRP ILE SER HIS ALA PHE CYS GLN TRP SEQRES 7 A 306 PHE VAL ARG GLU ALA VAL LEU THR TYR GLY TYR GLU SER SEQRES 8 A 306 HIS MET THR GLU PHE LEU ASN LYS LEU ASP PHE TYR VAL SEQRES 9 A 306 LEU PRO VAL LEU ASN ILE ASP GLY TYR ILE TYR THR TRP SEQRES 10 A 306 THR LYS ASN ARG MET TRP ARG LYS THR ARG SER THR ASN SEQRES 11 A 306 ALA GLY THR THR CYS ILE GLY THR ASP PRO ASN ARG ASN SEQRES 12 A 306 PHE ASP ALA GLY TRP CYS THR THR GLY ALA SER THR ASP SEQRES 13 A 306 PRO CYS ASP GLU THR TYR CYS GLY SER ALA ALA GLU SER SEQRES 14 A 306 GLU LYS GLU THR LYS ALA LEU ALA ASP PHE ILE ARG ASN SEQRES 15 A 306 ASN LEU SER SER ILE LYS ALA TYR LEU THR ILE HIS SER SEQRES 16 A 306 TYR SER GLN MET ILE LEU TYR PRO TYR SER TYR ASP TYR SEQRES 17 A 306 LYS LEU PRO GLU ASN ASN ALA GLU LEU ASN ASN LEU ALA SEQRES 18 A 306 LYS ALA ALA VAL LYS GLU LEU ALA THR LEU TYR GLY THR SEQRES 19 A 306 LYS TYR THR TYR GLY PRO GLY ALA THR THR ILE TYR PRO SEQRES 20 A 306 ALA ALA GLY GLY SER ASP ASP TRP ALA TYR ASP GLN GLY SEQRES 21 A 306 ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP LYS GLY SEQRES 22 A 306 ARG TYR GLY PHE ILE LEU PRO GLU SER GLN ILE GLN ALA SEQRES 23 A 306 THR CYS GLU GLU THR MET LEU ALA ILE LYS TYR VAL THR SEQRES 24 A 306 ASN TYR VAL LEU GLY HIS LEU SEQRES 1 B 306 THR THR GLY HIS SER TYR GLU LYS TYR ASN ASN TRP GLU SEQRES 2 B 306 THR ILE GLU ALA TRP THR LYS GLN VAL THR SER GLU ASN SEQRES 3 B 306 PRO ASP LEU ILE SER ARG THR ALA ILE GLY THR THR PHE SEQRES 4 B 306 LEU GLY ASN ASN ILE TYR LEU LEU LYS VAL GLY LYS PRO SEQRES 5 B 306 GLY PRO ASN LYS PRO ALA ILE PHE MET ASP CYS GLY PHE SEQRES 6 B 306 HIS ALA ARG GLU TRP ILE SER HIS ALA PHE CYS GLN TRP SEQRES 7 B 306 PHE VAL ARG GLU ALA VAL LEU THR TYR GLY TYR GLU SER SEQRES 8 B 306 HIS MET THR GLU PHE LEU ASN LYS LEU ASP PHE TYR VAL SEQRES 9 B 306 LEU PRO VAL LEU ASN ILE ASP GLY TYR ILE TYR THR TRP SEQRES 10 B 306 THR LYS ASN ARG MET TRP ARG LYS THR ARG SER THR ASN SEQRES 11 B 306 ALA GLY THR THR CYS ILE GLY THR ASP PRO ASN ARG ASN SEQRES 12 B 306 PHE ASP ALA GLY TRP CYS THR THR GLY ALA SER THR ASP SEQRES 13 B 306 PRO CYS ASP GLU THR TYR CYS GLY SER ALA ALA GLU SER SEQRES 14 B 306 GLU LYS GLU THR LYS ALA LEU ALA ASP PHE ILE ARG ASN SEQRES 15 B 306 ASN LEU SER SER ILE LYS ALA TYR LEU THR ILE HIS SER SEQRES 16 B 306 TYR SER GLN MET ILE LEU TYR PRO TYR SER TYR ASP TYR SEQRES 17 B 306 LYS LEU PRO GLU ASN ASN ALA GLU LEU ASN ASN LEU ALA SEQRES 18 B 306 LYS ALA ALA VAL LYS GLU LEU ALA THR LEU TYR GLY THR SEQRES 19 B 306 LYS TYR THR TYR GLY PRO GLY ALA THR THR ILE TYR PRO SEQRES 20 B 306 ALA ALA GLY GLY SER ASP ASP TRP ALA TYR ASP GLN GLY SEQRES 21 B 306 ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP LYS GLY SEQRES 22 B 306 ARG TYR GLY PHE ILE LEU PRO GLU SER GLN ILE GLN ALA SEQRES 23 B 306 THR CYS GLU GLU THR MET LEU ALA ILE LYS TYR VAL THR SEQRES 24 B 306 ASN TYR VAL LEU GLY HIS LEU SEQRES 1 C 306 THR THR GLY HIS SER TYR GLU LYS TYR ASN ASN TRP GLU SEQRES 2 C 306 THR ILE GLU ALA TRP THR LYS GLN VAL THR SER GLU ASN SEQRES 3 C 306 PRO ASP LEU ILE SER ARG THR ALA ILE GLY THR THR PHE SEQRES 4 C 306 LEU GLY ASN ASN ILE TYR LEU LEU LYS VAL GLY LYS PRO SEQRES 5 C 306 GLY PRO ASN LYS PRO ALA ILE PHE MET ASP CYS GLY PHE SEQRES 6 C 306 HIS ALA ARG GLU TRP ILE SER HIS ALA PHE CYS GLN TRP SEQRES 7 C 306 PHE VAL ARG GLU ALA VAL LEU THR TYR GLY TYR GLU SER SEQRES 8 C 306 HIS MET THR GLU PHE LEU ASN LYS LEU ASP PHE TYR VAL SEQRES 9 C 306 LEU PRO VAL LEU ASN ILE ASP GLY TYR ILE TYR THR TRP SEQRES 10 C 306 THR LYS ASN ARG MET TRP ARG LYS THR ARG SER THR ASN SEQRES 11 C 306 ALA GLY THR THR CYS ILE GLY THR ASP PRO ASN ARG ASN SEQRES 12 C 306 PHE ASP ALA GLY TRP CYS THR THR GLY ALA SER THR ASP SEQRES 13 C 306 PRO CYS ASP GLU THR TYR CYS GLY SER ALA ALA GLU SER SEQRES 14 C 306 GLU LYS GLU THR LYS ALA LEU ALA ASP PHE ILE ARG ASN SEQRES 15 C 306 ASN LEU SER SER ILE LYS ALA TYR LEU THR ILE HIS SER SEQRES 16 C 306 TYR SER GLN MET ILE LEU TYR PRO TYR SER TYR ASP TYR SEQRES 17 C 306 LYS LEU PRO GLU ASN ASN ALA GLU LEU ASN ASN LEU ALA SEQRES 18 C 306 LYS ALA ALA VAL LYS GLU LEU ALA THR LEU TYR GLY THR SEQRES 19 C 306 LYS TYR THR TYR GLY PRO GLY ALA THR THR ILE TYR PRO SEQRES 20 C 306 ALA ALA GLY GLY SER ASP ASP TRP ALA TYR ASP GLN GLY SEQRES 21 C 306 ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP LYS GLY SEQRES 22 C 306 ARG TYR GLY PHE ILE LEU PRO GLU SER GLN ILE GLN ALA SEQRES 23 C 306 THR CYS GLU GLU THR MET LEU ALA ILE LYS TYR VAL THR SEQRES 24 C 306 ASN TYR VAL LEU GLY HIS LEU HET ZN A 400 1 HET ZN B 500 1 HET ZN C 600 1 HET 343 A 401 45 HET 343 B 501 45 HET 343 C 601 45 HETNAM ZN ZINC ION HETNAM 343 (2S)-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL){[(S)-[(1R)- HETNAM 2 343 1-({N-[(BENZYLOXY)CARBONYL]-L-TYROSYL}AMINO)-2- HETNAM 3 343 METHYLPROPYL](HYDROXY)PHOSPHORYL]OXY}ACETIC ACID FORMUL 4 ZN 3(ZN 2+) FORMUL 7 343 3(C30 H36 N5 O9 P) FORMUL 10 HOH *578(H2 O) HELIX 1 1 ASN A 14 ASN A 29 1 16 HELIX 2 2 GLU A 72 TYR A 90 1 19 HELIX 3 3 GLU A 93 LEU A 103 1 11 HELIX 4 4 ASN A 112 LYS A 122 1 11 HELIX 5 5 ASP A 142 ASN A 146 5 5 HELIX 6 6 GLU A 173 ASN A 186 1 14 HELIX 7 7 ASN A 215 GLY A 235 1 21 HELIX 8 8 GLY A 243 ILE A 247 1 5 HELIX 9 9 GLY A 253 GLN A 261 1 9 HELIX 10 10 PRO A 282 SER A 284 5 3 HELIX 11 11 GLN A 285 HIS A 307 1 23 HELIX 12 12 ASN B 14 ASN B 29 1 16 HELIX 13 13 GLU B 72 TYR B 90 1 19 HELIX 14 14 GLU B 93 LEU B 103 1 11 HELIX 15 15 ASN B 112 LYS B 122 1 11 HELIX 16 16 ASP B 142 ASN B 146 5 5 HELIX 17 17 GLU B 173 ASN B 186 1 14 HELIX 18 18 ASN B 215 GLY B 235 1 21 HELIX 19 19 GLY B 243 ILE B 247 1 5 HELIX 20 20 GLY B 253 GLN B 261 1 9 HELIX 21 21 PRO B 282 SER B 284 5 3 HELIX 22 22 GLN B 285 HIS B 307 1 23 HELIX 23 23 ASN C 14 ASN C 29 1 16 HELIX 24 24 GLU C 72 TYR C 90 1 19 HELIX 25 25 GLU C 93 LEU C 103 1 11 HELIX 26 26 ASN C 112 LYS C 122 1 11 HELIX 27 27 ASP C 142 ASN C 146 5 5 HELIX 28 28 GLU C 173 ASN C 186 1 14 HELIX 29 29 ASN C 215 THR C 232 1 18 HELIX 30 30 GLY C 243 ILE C 247 1 5 HELIX 31 31 GLY C 253 GLN C 261 1 9 HELIX 32 32 PRO C 282 SER C 284 5 3 HELIX 33 33 GLN C 285 GLY C 306 1 22 SHEET 1 A 8 ILE A 33 THR A 40 0 SHEET 2 A 8 ASN A 46 VAL A 52 -1 O LEU A 49 N THR A 36 SHEET 3 A 8 ASP A 104 LEU A 108 -1 O PHE A 105 N VAL A 52 SHEET 4 A 8 ALA A 61 CYS A 66 1 N MET A 64 O TYR A 106 SHEET 5 A 8 ILE A 189 HIS A 196 1 O LYS A 190 N ALA A 61 SHEET 6 A 8 TYR A 265 GLU A 270 1 O PHE A 269 N HIS A 196 SHEET 7 A 8 MET A 201 TYR A 204 -1 N MET A 201 O GLU A 270 SHEET 8 A 8 THR A 239 PRO A 242 1 O THR A 239 N ILE A 202 SHEET 1 B 8 ILE B 33 THR B 40 0 SHEET 2 B 8 ASN B 46 VAL B 52 -1 O LYS B 51 N SER B 34 SHEET 3 B 8 ASP B 104 LEU B 108 -1 O PHE B 105 N VAL B 52 SHEET 4 B 8 ALA B 61 CYS B 66 1 N MET B 64 O TYR B 106 SHEET 5 B 8 ILE B 189 HIS B 196 1 O LYS B 190 N ALA B 61 SHEET 6 B 8 TYR B 265 GLU B 270 1 O TYR B 265 N TYR B 192 SHEET 7 B 8 MET B 201 TYR B 204 -1 N MET B 201 O GLU B 270 SHEET 8 B 8 THR B 239 PRO B 242 1 O THR B 239 N ILE B 202 SHEET 1 C 8 ILE C 33 THR C 40 0 SHEET 2 C 8 ASN C 46 VAL C 52 -1 O LYS C 51 N SER C 34 SHEET 3 C 8 ASP C 104 LEU C 108 -1 O VAL C 107 N LEU C 50 SHEET 4 C 8 ALA C 61 CYS C 66 1 N MET C 64 O TYR C 106 SHEET 5 C 8 ILE C 189 HIS C 196 1 O LEU C 193 N PHE C 63 SHEET 6 C 8 TYR C 265 GLU C 270 1 O PHE C 269 N HIS C 196 SHEET 7 C 8 MET C 201 TYR C 204 -1 N MET C 201 O GLU C 270 SHEET 8 C 8 THR C 239 PRO C 242 1 O THR C 239 N ILE C 202 SSBOND 1 CYS A 66 CYS A 79 1555 1555 2.03 SSBOND 2 CYS A 138 CYS A 161 1555 1555 2.03 SSBOND 3 CYS A 152 CYS A 166 1555 1555 2.03 SSBOND 4 CYS B 66 CYS B 79 1555 1555 2.03 SSBOND 5 CYS B 138 CYS B 161 1555 1555 2.02 SSBOND 6 CYS B 152 CYS B 166 1555 1555 2.03 SSBOND 7 CYS C 66 CYS C 79 1555 1555 2.03 SSBOND 8 CYS C 138 CYS C 161 1555 1555 2.03 SSBOND 9 CYS C 152 CYS C 166 1555 1555 2.04 CISPEP 1 SER A 197 TYR A 198 0 -3.48 CISPEP 2 PRO A 205 TYR A 206 0 2.98 CISPEP 3 ARG A 272 ASP A 273 0 -7.61 CISPEP 4 SER B 197 TYR B 198 0 -3.32 CISPEP 5 PRO B 205 TYR B 206 0 1.76 CISPEP 6 ARG B 272 ASP B 273 0 -6.11 CISPEP 7 SER C 197 TYR C 198 0 -4.77 CISPEP 8 PRO C 205 TYR C 206 0 -0.73 CISPEP 9 ARG C 272 ASP C 273 0 -5.40 SITE 1 AC1 4 HIS A 69 GLU A 72 HIS A 196 343 A 401 SITE 1 AC2 4 HIS B 69 GLU B 72 HIS B 196 343 B 501 SITE 1 AC3 4 HIS C 69 GLU C 72 HIS C 196 343 C 601 SITE 1 AC4 26 HIS A 69 ARG A 71 GLU A 72 ARG A 127 SITE 2 AC4 26 ASN A 144 ARG A 145 HIS A 196 SER A 197 SITE 3 AC4 26 TYR A 198 SER A 199 LEU A 203 SER A 207 SITE 4 AC4 26 ILE A 247 TYR A 248 ALA A 250 GLY A 253 SITE 5 AC4 26 ASP A 255 GLU A 270 PHE A 279 ZN A 400 SITE 6 AC4 26 HOH A 415 HOH A 422 HOH A 499 HOH A 502 SITE 7 AC4 26 HOH A 520 HOH A 538 SITE 1 AC5 26 LYS A 224 HIS B 69 ARG B 71 GLU B 72 SITE 2 AC5 26 ARG B 127 ASN B 144 ARG B 145 THR B 164 SITE 3 AC5 26 HIS B 196 SER B 197 TYR B 198 SER B 199 SITE 4 AC5 26 LEU B 203 SER B 207 ILE B 247 TYR B 248 SITE 5 AC5 26 ALA B 250 GLY B 253 ASP B 255 GLU B 270 SITE 6 AC5 26 PHE B 279 ZN B 500 HOH B 526 HOH B 558 SITE 7 AC5 26 HOH B 626 HOH B 665 SITE 1 AC6 23 HIS C 69 ARG C 71 GLU C 72 ARG C 127 SITE 2 AC6 23 ASN C 144 ARG C 145 HIS C 196 SER C 197 SITE 3 AC6 23 TYR C 198 SER C 199 LEU C 203 SER C 207 SITE 4 AC6 23 ILE C 247 TYR C 248 ALA C 250 GLY C 253 SITE 5 AC6 23 ASP C 255 GLU C 270 PHE C 279 ZN C 600 SITE 6 AC6 23 HOH C 605 HOH C 617 HOH C 658 CRYST1 66.487 95.350 135.279 90.00 90.00 90.00 P 21 21 21 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015041 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007392 0.00000 MASTER 411 0 6 33 24 0 23 6 0 0 0 72 END